Health Care & Life Sciences » Pharmaceuticals | Hisamitsu Pharmaceutical Co. Inc.

Hisamitsu Pharmaceutical Co. Inc. | Cash Flow

Fiscal year is March-February. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
33,727
29,416
27,922
29,984
27,694
25,673
Depreciation, Depletion & Amortization
7,492
7,613
8,545
7,368
6,005
5,742
Other Funds
295
276
290
110
123
10,958
Funds from Operations
31,957
27,100
28,211
25,175
27,278
20,458
Changes in Working Capital
3,888
3,868
2,712
5,265
3,175
4,686
Net Operating Cash Flow
35,845
23,232
30,923
19,910
30,453
15,772
Capital Expenditures
4,208
4,871
5,149
3,199
3,340
Sale of Fixed Assets & Businesses
6
117
54
54
82
Purchase/Sale of Investments
1,156
4,491
1,172
928
1,874
Net Investing Cash Flow
5,843
8,945
3,912
1,070
1,378
Cash Dividends Paid - Total
5,998
6,642
7,067
6,944
6,855
Issuance/Reduction of Debt, Net
180
117
81
193
171
Net Financing Cash Flow
6,476
7,036
11,616
18,402
7,153
Net Change in Cash
26,920
10,833
15,326
1,669
20,959
Free Cash Flow
31,756
18,541
25,871
16,785
27,322
Other Sources
14
300
11
3,287
6
Change in Capital Stock
3
1
4,178
11,152
2
Exchange Rate Effect
3,394
3,582
69
909
963
Other Uses
499
-
-
-
-

About Hisamitsu Pharmaceutical Co.

View Profile
Address
408 Tashiro Daikan-machi
Tosu Saga 841
Japan
Employees -
Website http://www.hisamitsu.co.jp
Updated 07/08/2019
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, Lifecella, and Keplat brands. It also provides ethical pharmaceuticals, over the counter drugs, medical devices, health supplements, and topical analgesic products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.